Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

A specific microRNA, chi-miR-30b-5p, slows down the growth of hair-related cells by affecting the CaMKIIδ gene in cashmere goats.

Proper skin toxicity management in chemotherapy is key to continuing treatment and keeping patient quality of life high.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

The document concludes that doctors should carefully consider off-label drug use in dermatology and always inform patients, while more research is needed on the safety and effectiveness of such practices.

Optimal long-acting finasteride injection dose found: 16.8 mg, effective for one month.

Combination therapy works best for female hair loss, increasing density and thickness.

Genetic variations affect dutasteride treatment response for male pattern hair loss.

AGA is a genetic, hormonal hair loss treated with finasteride, minoxidil, and supplements, but new compounds are being developed.

The document concludes that individualized Facial Feminization Surgery plans and comprehensive care are crucial for successful outcomes.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

The woman's hair loss is likely stress-related and should improve without treatment.

Men are increasingly seeking quick-result cosmetic treatments for their thicker, oilier skin and hair loss issues.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Darker hair colors may increase the risk of alopecia areata, while lighter hair colors may decrease it.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Myo-inositol supplements may improve insulin sensitivity and help with conditions like PCOS and gestational diabetes, but more research is needed.

Human skin can make serotonin and melatonin, which help protect and maintain it.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Melatonin may benefit skin health and could be a promising treatment in dermatology.

Protoporphyrin IX is useful in cancer treatment but can cause health problems if not properly regulated.

Nutraceuticals may improve skin health and protect against aging, but more research is needed on their optimal use and possible health risks.

Progress has been made in skin and nerve regeneration, but more research is needed to improve methods and ensure safety.

HFMs can help study hair growth and test potential hair growth drugs.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Oxidative stress damages hair and contributes to aging, and managing it can help maintain hair health.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.